These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 39364627)

  • 1. Factors Associated with HIV Viral Suppression in People Followed in an Outpatient Clinic in Angola During and After the COVID-19 Pandemic.
    Calcagno A; Pizzi C; Pocongo B; Ronzoni N; Alladio F; Francisco NM; Kalume A; Di Perri G; Gobbi F
    AIDS Patient Care STDS; 2024 Oct; 38(10):463-465. PubMed ID: 39364627
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.
    Cocorpus J; Holman S; Yager JE; Helzner E; Sardar M; Kohlhoff S; Smith-Norowitz TA
    AIDS Behav; 2024 Sep; 28(9):2961-2969. PubMed ID: 38836987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
    Giacomelli A; Bonazzetti C; Conti F; Pezzati L; Oreni L; Micheli V; Mancon A; Vimercati S; Albrecht M; Passerini M; Cossu MV; Capetti AF; Meraviglia P; Antinori S; Rizzardini G; Galli M; Ridolfo AL
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):299-304. PubMed ID: 34651605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining ART services during COVID-19 border closures: lessons learned in Namibia.
    Hans L; Hong SY; Ashipala LSN; Bikinesi L; Hamunime N; Kamangu JWN; Hatutale EJ; Dziuban EJ
    Lancet HIV; 2021 Jan; 8(1):e7. PubMed ID: 33387479
    [No Abstract]   [Full Text] [Related]  

  • 5. No Significant Effect of COVID-19 on Immunological and Virological Parameters in Patients With HIV-1 Infection.
    Calza L; Bon I; Borderi M; Colangeli V; Viale P
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):e6-e8. PubMed ID: 32568768
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging from the shadows: Trends in HIV ambulatory care, viral load testing, and viral suppression in a U.S. HIV cohort, 2019-2022: Impact of COVID-19 pandemic.
    Tedaldi E; Hou Q; Armon C; Mahnken JD; Palella F FJ; Simoncini G; Fuhrer J; Mayer C; Ewing A; Chagaris K; Carlson KJ; Li J; Buchacz K
    J Investig Med; 2024 Oct; 72(7):661-673. PubMed ID: 38666457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of SARS-CoV-2 pandemic on viral suppression for young adults living with perinatally acquired HIV infection.
    Hazell GA; Nott VR; Ayres S; Frize G; Kirkhope N; Fidler S; Foster C
    AIDS Care; 2024 Mar; 36(3):320-325. PubMed ID: 36007134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.
    Ceballos ME; Ross P; Lasso M; Dominguez I; Puente M; Valenzuela P; Enberg M; Serri M; Muñoz R; Pinos Y; Silva M; Noguera M; Dominguez A; Zamora F;
    Int J STD AIDS; 2021 Apr; 32(5):435-443. PubMed ID: 33533294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and variables associated with COVID-19 morbidity and mortality in Luanda, Angola, in the first year of the pandemic.
    Arrais ML; Dias WAF; Silva MPA; Neto LES; Pedro NMF; Jungo SFI; Miguel ARC; Fortes-Gabriel EMV; Sebastião CS; Gama JMR; Brito MD
    Afr Health Sci; 2023 Dec; 23(4):51-63. PubMed ID: 38974263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
    Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
    Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients?
    Di Biagio A; Taramasso L; Dentone C; Vena A; Giacobbe DR; De Maria A; Mikulska M; Bassetti M;
    AIDS; 2020 Oct; 34(12):1865-1867. PubMed ID: 32889857
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Denoeud-Ndam L; Stecker C; Andifasi P; Mushavi A; Maphosa T; Zondo M; Murandu M; Gombakomba G; Katirayi L; Mungati M; Bailey R; Weber R; Rivadeneira E; Hrapcak S
    Pediatr Infect Dis J; 2023 Jul; 42(7):573-575. PubMed ID: 37000925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida.
    Algarin AB; Varas-Rodríguez E; Valdivia C; Fennie KP; Larkey L; Hu N; Ibañez GE
    AIDS Behav; 2020 Aug; 24(8):2236-2238. PubMed ID: 32303923
    [No Abstract]   [Full Text] [Related]  

  • 17. Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.
    Nellen JF; Wit FW; De Wolf F; Jurriaans S; Lange JM; Prins JM
    J Acquir Immune Defic Syndr; 2004 Aug; 36(4):943-50. PubMed ID: 15220701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium.
    El Moussaoui M; Lambert N; Maes N; Fombellida K; Vaira D; Moutschen M; Darcis G
    HIV Res Clin Pract; 2021 Jun; 22(3):63-70. PubMed ID: 34308800
    [No Abstract]   [Full Text] [Related]  

  • 20. Short Communication: HIV Viral Load Trends During the Coronavirus Disease 2019 Pandemic in a Reference Center for HIV in Rome, Italy.
    Latini A; Donà MG; Giuliani M; Pontone M; Ancona C; Foracappa S; Morrone A; Zaccarelli M
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):624-626. PubMed ID: 33966477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.